Frequency distribution of apoprotein(a) isoforms in patients with diabetes mellitus and healthy subjects

Croatian Medical Journal

Volumn 44, Issue 4, 2003, Pages 435-440

  Labudović, Danica D ^a,c   Toseska, Katerina N ^a   Alabakovska, Sonja B ^a   Dimitrovski, Cedo ^b   Jurhar, Maja ^a   Isjanovska, Rozalinda ^c   Spiroski, Mirko ^a   Todorova, Bojana B ^a  

^a Dept of Med and Exp Biochemistry ^*  (Macedonia)

^b Endocrinology Clinic   (Macedonia)

^c SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

Author keywords

Apoproteins; Arteriosclerosis; Diabetes mellitus, insulin dependent; Diabetes mellitus, non insulin dependent; Gene frequency; Macedonia (Republic)

Indexed keywords

APOLIPOPROTEIN A; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HUMAN; IMMUNOBLOTTING; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYACRYLAMIDE GEL ELECTROPHORESIS; RISK FACTOR;

ADULT; AGE DISTRIBUTION; AGED; APOLIPOPROTEINS A; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CROATIA; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROBABILITY; PROTEIN ISOFORMS; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 0041336714     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 330:132-7.
2. Marcovina SM, Morrisett JD. Structure and metabolism of lipoprotein(a). Curr Opin Lipidol 1995;6:136-45.
3. Gaubatz JW, Ghanem KI, Guevara J Jr, Nava ML, Patsch W, Morrisett JD. Polymorphic forms of human apoliporotein (a): inheritance and relationship of their molecular weights to plasma levels of lipoprotein(a). J Lipid Res 1990;31:603-13.
4. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987;80:458-65.
5. Marcovina SM, Zhang Zh, Gaur VP, Albers JJ. Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem Biophys Res Commun 1993;191:1192-6.
6. Dieplinger H, Kronenberg F. Genetics and metabolism of lipoprotein(a) and clinical implications (Part 2). Wien Klin Wochenschr 1999;111:46-55.
7. Levitsky LL, Scanu AM, Gould SH. Lipoprotein(a) levels in black and white children and adolescents with IDDM. Diabetes Care 1991;14:283-7.
8. Csaszar A, Dieplinger H, Sandholzer C, Karadi I, Juhasz E, Drexel H, et al. Plasma lipoprotein(a) concentration and phenotypes in diabetes mellitus. Diabetologia 1993;36:47-51.
9. Rainwater DL, MacCluer JW, Stern MP, VandeBerg JL, Haffner SM. Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size. Diabetes 1994; 43:942-6.
10. Haffner SM, Moss SE, Klein BE, Klein R. Lack of association between lipoprotein(a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Metabolism 1992;41:194-7.
11. Ruiz J, Thillet J, Huby T, James RW, Erlich D, Flandre P, et al. Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes. Diabetologia 1994;37;585-91.
12. Hiraga T, Kobayashi T, Okubo M, Nakanishi K, Sugimoto T, Ohashi Y, et al. Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes. Diabetes Care 1995;18:241-4.
13. Kraft HG, Lingenhel A, Kochl S, Hoppichler F, Kronenberg F, Abe A, et al. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol 1996;16:713-9.
14. Gazzaruso C, Buscaglia P, Garzaniti A, Falcone C, Mariotti S, Savino S, et al. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension. J Hypertens 1997;15:227-35.
15. Kronenberg F, Neyer U, Lhotta K, Trenkwalder E, Auinger M, Pribasnig A, et al. The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up. J Am Soc Nephrol 1999;10: 1027-36.
16. Paultre F, Pearson TA, Weil HF, Tuck CH, Myerson M, Rubin J, et al. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Arterioscler Thromb Vasc Biol 2000;20:2619-25.
17. Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, Fratino P. Silent coronary artery disease in type 2 diabetes mellitus: the role of Lp(a), homocysteine and apo(a) polymorphism. Cardiovasc Diabetol 2002;1:5.
18. World Health Organization Study Group. Diabetes mellitus. Technical Report Series No. 727. Geneva: WHO; 1985.
19. Rainwater DL. Genetic basis for multimodal relationship between apolipoprotein(a) size and lipoprotein(a) concentration in Mexican-Americans. Atherosclerosis 1995;115:165-71.
20. Labudović D, Todorova B, Rainwater D, Alabakovska S, Toseska K. Apoprotein(a) isoform separation by 3-15% gradient SDS denaturating polyacrylamide gel electrophoresis. Maked Med Preg 1999;3-4:126-31.
21. Rainwater DL, Kammerer CM, VanderBerg JL, Hixson JE. Characterization of the genetic elements controlling lipoprotein(a) concentrations in Mexican Americans. Evidence for at least three controlling elements linked to LPA, the locus encoding apolipoprotein(a). Atherosclerosis 1997;128:223-33.
22. Rainwater DL, Haffner SM. Insulin and 2-hour glucose levels are inversly related to Lp(a) concentrations for LPA genotype. Arterioscler Thromb Vasc Biol 1998;18: 1335-41.
23. Sandholzer C, Saha N, Kark JD, Rees A, Jaross W, Dieplinger H, et al. Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler Thromb 1992;12:1214-26.
24. Kronenberg F, Kronenberg MF, Kiechl S, Trenkwalder E, Santer P, Oberhollenzer F, et al. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation 1999;100:1154-60.
25. Gazzaruso C, Garzaniti A, Buscaglia P, D'Annunzio G, Porta A, Vandelli G, et al. Lipoprotein(a) levels and apolipoprotein(a) polymorphisms in type 1 diabetes mellitus: relationships to microvascular and neurological complications. Acta Diabetol 1998;35:13-8.
26. Ribault A, Durou MR, Letellier C, Wojcik F, Poirier JY, Ruelland A. Determination of lipoprotein(a) concentrations and lipoprotein(a) molecular weights in diabetic patients. Diabetes Metab 2000;26:107-12.
27. Klausen IC, Schmidt EB, Lervang HH, Gerdes LU, Ditzel J, Faergeman O. Normal lipoprotein(a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest 1992;22:538-41.
28. Stewart MW, Webster JM, Humphriss D, Berrish T, Walker M, Laker MF. Lipoprotein (a) concentrations and apolipoprotein(a) in normoglycaemic relatives of type 2 diabetic patients. Atherosclerosis 1996;124:119-24.
29. Hernandez C, Chacon P, Garcia-Pascual L, Mesa J, Simo R. Relationship between lipoprotein(a) phenotypes and plasminogen activator inhibitor type 1 in diabetic patients. Thromb Res 2000;99:119-27.
30. Labudovic D, Toseska K, Alabakovska S, Todorova B. Apoprotein(a) phenotypes and plasma lipoprotein(a) concentration in patients with diabetes mellitus. Clin Biochem. In press 2003.
31. Brown SA, Morrisett JD, Boerwinkle E, Hutchinson R, Patsch W. The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993; 13;1558-66.
32. Lundstam U, Herlitz J, Karlsson T, Linden T, Wiklund O. Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease. J Intern Med 2002;251:111-8.
33. Doucet C, Huby T, Ruiz J, Chapman MJ, Thillet J. Nonenzymatic glycation of lipoprotein(a) in vitro and in vivo. Atherosclerosis 1995;118:135-43.
34. Klaya F, Durlach V, Bertin E, Monier F, Monboisse JC, Gillery P. Evaluation of serum glycated lipoprotein(a) levels in non-insulin-dependent diabetic patients. Clin Biochem 1997;30:227-30.